Cargando…
Angiostatin anti-angiogenesis requires IL-12: The innate immune system as a key target
BACKGROUND: Angiostatin, an endogenous angiogenesis inhibitor, is a fragment of plasminogen. Its anti-angiogenic activity was discovered with functional assays in vivo, however, its direct action on endothelial cells is moderate and identification of definitive mechanisms of action has been elusive...
Autores principales: | Albini, Adriana, Brigati, Claudio, Ventura, Agostina, Lorusso, Girieca, Pinter, Marta, Morini, Monica, Mancino, Alessandra, Sica, Antonio, Noonan, Douglas M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2630934/ https://www.ncbi.nlm.nih.gov/pubmed/19144161 http://dx.doi.org/10.1186/1479-5876-7-5 |
Ejemplares similares
-
Regulation of angiogenesis by angiostatin through immune cells and IL 12 production
por: Noonan, Douglas M, et al.
Publicado: (2006) -
Innate Immune Cells and Their Contribution to T-Cell-Based Immunotherapy
por: Ginefra, Pierpaolo, et al.
Publicado: (2020) -
Treatment of medulloblastoma with oncolytic measles viruses expressing the angiogenesis inhibitors endostatin and angiostatin
por: Hutzen, Brian, et al.
Publicado: (2014) -
Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy
por: Albini, Adriana, et al.
Publicado: (2018) -
Linoleic acid enhances angiogenesis through suppression of angiostatin induced by plasminogen activator inhibitor 1
por: Nishioka, N, et al.
Publicado: (2011)